HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - FR0010557264 - AB) announces ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Scientists have discovered a potential new way to treat one of the most aggressive blood cancers, offering hope to thousands ...

Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, and Weill Cornell Medicine have entered into ...

US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...

"The gratitude I have for everything in life now is that much greater," he said. "I don't know how close to death I was, but ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 patients with newly diagnosed acute myeloid leukemia (AML) identifies an eight-protein signature that enhances risk stratification.

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.